Selected research
Industry Research
Nicotinamide Riboside (NR) Industry Research Report 2026
Market perspective
The global Nicotinamide Riboside (NR) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nicotinamide Riboside (NR) is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nicotinamide Riboside (NR) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nicotinamide Riboside (NR) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nicotinamide Riboside (NR) include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nicotinamide Riboside (NR) market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Nicotinamide Riboside (NR).
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nicotinamide Riboside (NR) Market by Company
ChromaDex
Genex Formulas
Bontac
Tiantai Biotechnology
Zhejiang Jiahua
Shandong Tianming Pharmaceutical
Suzhou MyLand Pharm & Nutrition
EnzymeWorks
Longer Livetech
Shenzhen Ejion Biotechnology
Nicotinamide Riboside (NR) Segment by Type
Purity ≤98%
Purity ＞98%
Nicotinamide Riboside (NR) Segment by Application
Health Supplement
Pharmaceutical Additives
Nicotinamide Riboside (NR) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicotinamide Riboside (NR) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicotinamide Riboside (NR) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≤98%
- Purity ＞98%
Applications
- Health Supplement
- Pharmaceutical Additives
Companies covered
- ChromaDex
- Genex Formulas
- Bontac
- Tiantai Biotechnology
- Zhejiang Jiahua
- Shandong Tianming Pharmaceutical
- Suzhou MyLand Pharm & Nutrition
- EnzymeWorks
- Longer Livetech
- Shenzhen Ejion Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nicotinamide Riboside (NR) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity ≤98%
- 2.2.3 Purity ＞98%
- 2.3 Nicotinamide Riboside (NR) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Health Supplement
- 2.3.3 Pharmaceutical Additives
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Nicotinamide Riboside (NR) Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Nicotinamide Riboside (NR) Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Nicotinamide Riboside (NR) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nicotinamide Riboside (NR) Production by Manufacturers (2021-2026)
- 3.2 Global Nicotinamide Riboside (NR) Production Value by Manufacturers (2021-2026)
- 3.3 Global Nicotinamide Riboside (NR) Average Price by Manufacturers (2021-2026)
- 3.4 Global Nicotinamide Riboside (NR) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nicotinamide Riboside (NR) Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Nicotinamide Riboside (NR) Manufacturers, Product Type & Application
- 3.7 Global Nicotinamide Riboside (NR) Manufacturers Established Date
- 3.8 Global Nicotinamide Riboside (NR) Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ChromaDex
- 4.1.1 ChromaDex Nicotinamide Riboside (NR) Company Information
- 4.1.2 ChromaDex Nicotinamide Riboside (NR) Business Overview
- 4.1.3 ChromaDex Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 ChromaDex Product Portfolio
- 4.1.5 ChromaDex Recent Developments
- 4.2 Genex Formulas
- 4.2.1 Genex Formulas Nicotinamide Riboside (NR) Company Information
- 4.2.2 Genex Formulas Nicotinamide Riboside (NR) Business Overview
- 4.2.3 Genex Formulas Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Genex Formulas Product Portfolio
- 4.2.5 Genex Formulas Recent Developments
- 4.3 Bontac
- 4.3.1 Bontac Nicotinamide Riboside (NR) Company Information
- 4.3.2 Bontac Nicotinamide Riboside (NR) Business Overview
- 4.3.3 Bontac Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Bontac Product Portfolio
- 4.3.5 Bontac Recent Developments
- 4.4 Tiantai Biotechnology
- 4.4.1 Tiantai Biotechnology Nicotinamide Riboside (NR) Company Information
- 4.4.2 Tiantai Biotechnology Nicotinamide Riboside (NR) Business Overview
- 4.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Tiantai Biotechnology Product Portfolio
- 4.4.5 Tiantai Biotechnology Recent Developments
- 4.5 Zhejiang Jiahua
- 4.5.1 Zhejiang Jiahua Nicotinamide Riboside (NR) Company Information
- 4.5.2 Zhejiang Jiahua Nicotinamide Riboside (NR) Business Overview
- 4.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Zhejiang Jiahua Product Portfolio
- 4.5.5 Zhejiang Jiahua Recent Developments
- 4.6 Shandong Tianming Pharmaceutical
- 4.6.1 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Company Information
- 4.6.2 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Business Overview
- 4.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Shandong Tianming Pharmaceutical Product Portfolio
- 4.6.5 Shandong Tianming Pharmaceutical Recent Developments
- 4.7 Suzhou MyLand Pharm & Nutrition
- 4.7.1 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Company Information
- 4.7.2 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Business Overview
- 4.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Suzhou MyLand Pharm & Nutrition Product Portfolio
- 4.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
- 4.8 EnzymeWorks
- 4.8.1 EnzymeWorks Nicotinamide Riboside (NR) Company Information
- 4.8.2 EnzymeWorks Nicotinamide Riboside (NR) Business Overview
- 4.8.3 EnzymeWorks Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 EnzymeWorks Product Portfolio
- 4.8.5 EnzymeWorks Recent Developments
- 4.9 Longer Livetech
- 4.9.1 Longer Livetech Nicotinamide Riboside (NR) Company Information
- 4.9.2 Longer Livetech Nicotinamide Riboside (NR) Business Overview
- 4.9.3 Longer Livetech Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Longer Livetech Product Portfolio
- 4.9.5 Longer Livetech Recent Developments
- 4.10 Shenzhen Ejion Biotechnology
- 4.10.1 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Company Information
- 4.10.2 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Business Overview
- 4.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Shenzhen Ejion Biotechnology Product Portfolio
- 4.10.5 Shenzhen Ejion Biotechnology Recent Developments
5 Global Nicotinamide Riboside (NR) Production by Region
- 5.1 Global Nicotinamide Riboside (NR) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nicotinamide Riboside (NR) Production by Region: 2021-2032
- 5.2.1 Global Nicotinamide Riboside (NR) Production by Region: 2021-2026
- 5.2.2 Global Nicotinamide Riboside (NR) Production Forecast by Region (2027-2032)
- 5.3 Global Nicotinamide Riboside (NR) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Nicotinamide Riboside (NR) Production Value by Region: 2021-2032
- 5.4.1 Global Nicotinamide Riboside (NR) Production Value by Region: 2021-2026
- 5.4.2 Global Nicotinamide Riboside (NR) Production Value Forecast by Region (2027-2032)
- 5.5 Global Nicotinamide Riboside (NR) Market Price Analysis by Region (2021-2026)
- 5.6 Global Nicotinamide Riboside (NR) Production and Value, YOY Growth
- 5.6.1 North America Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021-2032)
6 Global Nicotinamide Riboside (NR) Consumption by Region
- 6.1 Global Nicotinamide Riboside (NR) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Nicotinamide Riboside (NR) Consumption by Region (2021-2032)
- 6.2.1 Global Nicotinamide Riboside (NR) Consumption by Region: 2021-2026
- 6.2.2 Global Nicotinamide Riboside (NR) Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.4 Europe
- 6.4.1 Europe Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 China Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Nicotinamide Riboside (NR) Production by Type (2021-2032)
- 7.1.1 Global Nicotinamide Riboside (NR) Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Nicotinamide Riboside (NR) Production Market Share by Type (2021-2032)
- 7.2 Global Nicotinamide Riboside (NR) Production Value by Type (2021-2032)
- 7.2.1 Global Nicotinamide Riboside (NR) Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Nicotinamide Riboside (NR) Production Value Market Share by Type (2021-2032)
- 7.3 Global Nicotinamide Riboside (NR) Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Nicotinamide Riboside (NR) Production by Application (2021-2032)
- 8.1.1 Global Nicotinamide Riboside (NR) Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Nicotinamide Riboside (NR) Production Market Share by Application (2021-2032)
- 8.2 Global Nicotinamide Riboside (NR) Production Value by Application (2021-2032)
- 8.2.1 Global Nicotinamide Riboside (NR) Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Nicotinamide Riboside (NR) Production Value Market Share by Application (2021-2032)
- 8.3 Global Nicotinamide Riboside (NR) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Nicotinamide Riboside (NR) Value Chain Analysis
- 9.1.1 Nicotinamide Riboside (NR) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Nicotinamide Riboside (NR) Production Mode & Process
- 9.2 Nicotinamide Riboside (NR) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nicotinamide Riboside (NR) Distributors
- 9.2.3 Nicotinamide Riboside (NR) Customers
10 Global Nicotinamide Riboside (NR) Analyzing Market Dynamics
- 10.1 Nicotinamide Riboside (NR) Industry Trends
- 10.2 Nicotinamide Riboside (NR) Industry Drivers
- 10.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
- 10.4 Nicotinamide Riboside (NR) Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst